UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One) |
||||||
[X] |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|||||
|
For the quarterly period ended September 30, 2006 |
|||||
OR |
||||||
[ ] |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|||||
|
For the transition period from |
|
to |
|
|
|
|
||||||
Commission File Number: 001-07434 |
||||||
Aflac Incorporated |
|
|
(Exact name of registrant as specified in its charter) |
GEORGIA |
58-1167100 |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
|
|
1932 Wynnton Road, Columbus, Georgia |
31999 |
(Address of principal executive offices) |
(ZIP Code) |
|
|
706.323.3431 |
|
(Registrants telephone number, including area code) |
|
|
|
(Former name, former address and former fiscal year, if changed since last report) |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past |
|
90 days. |
þ Yes o No |
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of accelerated filer and large accelerated filer in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer þ |
Accelerated filer o |
Non-accelerated filer o |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). |
|
|
o Yes þ No |
Indicate the number of shares outstanding of each of the issuers classes of common stock, as of the latest practicable date.
Class |
|
|
October 31, 2006 |
||
Common Stock, $.10 Par Value |
|
|
494,503,936 shares |
||
Aflac Incorporated and Subsidiaries
Table of Contents
Items other than those listed above are omitted because they are not required or are not applicable.
i
Aflac Incorporated and Subsidiaries
Consolidated Statements of Earnings
|
Three Months |
|
Nine Months |
|
|||||
|
|
Ended |
|
Ended |
|
||||
|
|
September 30, |
|
September 30, |
|
||||
(In millions, except for share and per-share amounts - Unaudited) |
|
2006 |
|
2005 |
|
2006 |
|
2005 |
|
Revenues: |
|
|
|
|
|
|
|
|
|
Premiums, principally supplemental health insurance |
|
$3,102 |
|
$2,997 |
|
$9,200 |
|
$9,058 |
|
Net investment income |
|
548 |
|
522 |
|
1,614 |
|
1,554 |
|
Realized investment gains (losses) |
|
11 |
|
140 |
|
75 |
|
155 |
|
Other income (losses) |
|
11 |
|
10 |
|
40 |
|
29 |
|
Total revenues |
|
3,672 |
|
3,669 |
|
10,929 |
|
10,796 |
|
Benefits and expenses: |
|
|
|
|
|
|
|
|
|
Benefits and claims |
|
2,291 |
|
2,237 |
|
6,715 |
|
6,733 |
|
Acquisition and operating expenses: |
|
|
|
|
|
|
|
|
|
Amortization of deferred policy acquisition costs |
|
137 |
|
129 |
|
425 |
|
399 |
|
Insurance commissions |
|
325 |
|
319 |
|
975 |
|
986 |
|
Insurance expenses |
|
334 |
|
311 |
|
973 |
|
922 |
|
Interest expense |
|
4 |
|
6 |
|
14 |
|
17 |
|
Other operating expenses |
|
24 |
|
22 |
|
71 |
|
72 |
|
Total acquisition and operating expenses |
|
824 |
|
787 |
|
2,458 |
|
2,396 |
|
Total benefits and expenses |
|
3,115 |
|
3,024 |
|
9,173 |
|
9,129 |
|
Earnings before income taxes |
|
557 |
|
645 |
|
1,756 |
|
1,667 |
|
Income taxes |
|
190 |
|
190 |
|
606 |
|
548 |
|
Net earnings |
|
$ 367 |
|
$ 455 |
|
$1,150 |
|
$1,119 |
|
Net earnings per share: |
|
|
|
|
|
|
|
|
|
Basic |
|
$ .74 |
|
$ .91 |
|
$ 2.32 |
|
$ 2.23 |
|
Diluted |
|
.73 |
|
.90 |
|
2.29 |
|
2.20 |
|
Common shares used in computing earnings
per share |
|
|
|
|
|
|
|
|
|
Basic |
|
494,923 |
|
500,557 |
|
496,626 |
|
501,555 |
|
Diluted |
|
500,952 |
|
507,323 |
|
502,926 |
|
508,250 |
|
Cash dividends per share |
|
$ .13 |
|
$ .11 |
|
$ .39 |
|
$ .33 |
|
See the accompanying Notes to the Consolidated Financial Statements.
1
Aflac
Incorporated and Subsidiaries
Consolidated Balance Sheets
|
September 30, |
|
December 31, |
|
|
(In millions - Unaudited) |
|
2006 |
|
2005 |
|
Assets: |
|
|
|
|
|
Investments and cash: |
|
|
|
|
|
Securities available for sale, at fair value: |
|
|
|
|
|
Fixed maturities (amortized cost $26,454 in 2006 |
|
$ 27,938 |
|
$ 28,142 |
|
Perpetual debentures (amortized cost $4,259 in 2006 |
|
4,256 |
|
4,370 |
|
Equity securities (cost $17 in 2006 and $30 in 2005) |
|
38 |
|
84 |
|
Securities held to maturity, at amortized cost: |
|
|
|
|
|
Fixed maturities (fair value $12,451 in 2006 |
|
12,864 |
|
10,867 |
|
Perpetual debentures (fair value $4,150 in 2006 |
|
4,157 |
|
4,172 |
|
Other investments |
|
55 |
|
57 |
|
Cash and cash equivalents |
|
1,378 |
|
1,297 |
|
Total investments and cash |
|
50,686 |
|
48,989 |
|
Receivables, primarily premiums |
|
522 |
|
479 |
|
Receivables for security transactions |
|
- |
|
105 |
|
Accrued investment income |
|
506 |
|
484 |
|
Deferred policy acquisition costs |
|
5,930 |
|
5,590 |
|
Property and equipment, at cost less accumulated depreciation |
|
450 |
|
448 |
|
Other |
|
259 |
|
266 |
|
Total assets |
|
$ 58,353 |
|
$ 56,361 |
|
See the accompanying Notes to the Consolidated Financial Statements.
(continued)
2
Aflac
Incorporated and Subsidiaries
Consolidated Balance Sheets (continued)
|
September 30, |
|
December 31, |
|
|||||||
(In millions, except for share and per-share amounts - Unaudited) |
|
2006 |
|
2005 |
|
||||||
Liabilities and shareholders equity: |
|
|
|
|
|
|
|
|
|
||
Liabilities: |
|
|
|
|
|
|
|
|
|
||
Policy liabilities: |
|
|
|
|
|
|
|
|
|
||
Future policy benefits |
|
|
$ |
40,142 |
|
|
|
$ |
37,853 |
|
|
Unpaid policy claims |
|
|
2,660 |
|
|
|
2,504 |
|
|
||
Unearned premiums |
|
|
639 |
|
|
|
594 |
|
|
||
Other policyholders funds |
|
|
1,527 |
|
|
|
1,378 |
|
|
||
Total policy liabilities |
|
|
44,968 |
|
|
|
42,329 |
|
|
||
Notes payable |
|
|
1,439 |
|
|
|
1,395 |
|
|
||
Income taxes |
|
|
2,260 |
|
|
|
2,577 |
|
|
||
Payables for return of cash collateral on loaned securities |
|
|
440 |
|
|
|
622 |
|
|
||
Other |
|
|
1,219 |
|
|
|
1,511 |
|
|
||
Commitments and contingent liabilities (Notes 8 and 9) |
|
|
|
|
|
|
|
|
|
||
Total liabilities |
|
|
50,326 |
|
|
|
48,434 |
|
|
||
Shareholders equity: |
|
|
|
|
|
|
|
|
|
||
Common stock of $.10 par value. In thousands: |
|
|
|
|
|
|
|
|
|
||
authorized 1,000,000 shares; issued 655,366 |
|
|
|
|
|
|
|
|
|
||
shares in 2006 and 654,522 shares in 2005 |
|
|
66 |
|
|
|
65 |
|
|
||
Additional paid-in capital |
|
|
866 |
|
|
|
791 |
|
|
||
Retained earnings |
|
|
9,005 |
|
|
|
8,048 |
|
|
||
Accumulated other comprehensive income: |
|
|
|
|
|
|
|
|
|
||
Unrealized foreign currency translation gains |
|
|
74 |
|
|
|
77 |
|
|
||
Unrealized gains on investment securities |
|
|
1,275 |
|
|
|
1,917 |
|
|
||
Minimum pension liability adjustment |
|
|
(37 |
) |
|
|
(37 |
) |
|
||
Treasury stock, at average cost |
|
|
(3,222 |
) |
|
|
(2,934 |
) |
|
||
Total shareholders equity |
|
|
8,027 |
|
|
|
7,927 |
|
|
||
Total liabilities and shareholders equity |
|
|
$ |
58,353 |
|
|
|
$ |
56,361 |
|
|
Shareholders equity per share |
|
|
$ |
16.23 |
|
|
|
$ |
15.89 |
|
|
See the accompanying Notes to the Consolidated Financial Statements.
3
Aflac
Incorporated and Subsidiaries
Consolidated Statements of Shareholders Equity
Nine Months Ended September 30, |
|||||||
(In millions, except for per-share amounts - Unaudited) |
|
2006 |
|
2005 |
|
||
Common stock: |
|
|
|
|
|
||
Balance, beginning of period |
|
$ |
65 |
|
$ |
65 |
|
Exercise of stock options |
|
1 |
|
- |
|
||
Balance, end of period |
|
66 |
|
65 |
|
||
Additional paid-in capital: |
|
|
|
|
|
||
Balance, beginning of period |
|
791 |
|
676 |
|
||
Exercise of stock options, including income tax benefits |
|
22 |
|
33 |
|
||
Share-based compensation |
|
25 |
|
23 |
|
||
Gain on treasury stock reissued |
|
28 |
|
22 |
|
||
Balance, end of period |
|
866 |
|
754 |
|
||
Retained earnings: |
|
|
|
|
|
||
Balance, beginning of period |
|
8,048 |
|
6,785 |
|
||
Net earnings |
|
1,150 |
|
1,119 |
|
||
Dividends to shareholders ($.39 per share in 2006
and |
|
(193 |
) |
(166 |
) |
||
Balance, end of period |
|
9,005 |
|
7,738 |
|
||
Accumulated other comprehensive income: |
|
|
|
|
|
||
Balance, beginning of period |
|
1,957 |
|
2,611 |
|
||
Change in unrealized foreign currency translation
gains (losses) |
|
(3 |
) |
(95 |
) |
||
Change in unrealized gains (losses) on investment securities |
|
(642 |
) |
(241 |
) |
||
Minimum pension liability adjustment during period, |
|
- |
|
1 |
|
||
Balance, end of period |
|
1,312 |
|
2,276 |
|
||
Treasury stock: |
|
|
|
|
|
||
Balance, beginning of period |
|
(2,934 |
) |
(2,561 |
) |
||
Purchases of treasury stock |
|
(327 |
) |
(317 |
) |
||
Cost of shares issued |
|
39 |
|
51 |
|
||
Balance, end of period |
|
(3,222 |
) |
(2,827 |
) |
||
Total shareholders equity |
|
$ |
8,027 |
|
$ |
8,006 |
|
See the accompanying Notes to the Consolidated Financial Statements.
4
Aflac Incorporated
and Subsidiaries
Consolidated Statements of Cash Flows
Nine Months Ended September 30, |
|||||||
(In millions - Unaudited) |
|
2006 |
|
2005 |
|
||
Cash flows from operating activities: |
|
|
|
|
|
||
Net earnings |
|
$ |
1,150 |
|
$ |
1,119 |
|
Adjustments to reconcile net earnings to net cash |
|
|
|
|
|
||
Change in receivables and advance premiums |
|
(28 |
) |
(23 |
) |
||
Increase in deferred policy acquisition costs |
|
(339 |
) |
(339 |
) |
||
Increase in policy liabilities |
|
2,473 |
|
2,555 |
|
||
Change in income tax liabilities |
|
(8 |
) |
177 |
|
||
Realized investment (gains) losses |
|
(75 |
) |
(155 |
) |
||
Other, net |
|
71 |
|
130 |
|
||
Net cash provided by operating activities |
|
3,244 |
|
3,464 |
|
||
Cash flows from investing activities: |
|
|
|
|
|
||
Proceeds from investments sold or matured: |
|
|
|
|
|
||
Securities available for sale: |
|
|
|
|
|
||
Fixed maturities sold |
|
2,046 |
|
1,840 |
|
||
Fixed maturities matured |
|
257 |
|
490 |
|
||
Perpetual debentures sold |
|
1 |
|
35 |
|
||
Equity securities sold |
|
46 |
|
- |
|
||
Costs of investments acquired: |
|
|
|
|
|
||
Securities available for sale: |
|
|
|
|
|
||
Fixed maturities |
|
(3,001 |
) |
(2,580 |
) |
||
Perpetual debentures |
|
- |
|
(429 |
) |
||
Securities held to maturity: |
|
|
|
|
|
||
Fixed maturities |
|
(2,033 |
) |
(2,290 |
) |
||
Cash received as collateral on loaned securities, net |
|
(186 |
) |
(2,558 |
) |
||
Other, net |
|
(14 |
) |
(19 |
) |
||
Net cash used by investing activities |
|
$ |
(2,884 |
) |
$ |
(5,511 |
) |
See the accompanying Notes to the Consolidated Financial Statements.
(continued)
5
Aflac
Incorporated and Subsidiaries
Consolidated Statements of Cash Flows (continued)
Nine Months Ended September 30, |
|||||||
(In millions - Unaudited) |
|
2006 |
|
2005 |
|
||
Cash flows from financing activities: |
|
|
|
|
|
||
Proceeds from borrowings |
|
$ |
382 |
|
$ |
360 |
|
Principal payments under debt obligations |
|
(360 |
) |
(6 |
) |
||
Purchases of treasury stock |
|
(327 |
) |
(317 |
) |
||
Change in investment-type contracts, net |
|
157 |
|
195 |
|
||
Dividends paid to shareholders |
|
(183 |
) |
(158 |
) |
||
Treasury stock reissued |
|
29 |
|
39 |
|
||
Other, net |
|
19 |
|
33 |
|
||
Net cash (used) provided by financing activities |
|
(283 |
) |
146 |
|
||
Effect of exchange rate changes on cash and cash equivalents |
|
4 |
|
(50 |
) |
||
Net change in cash and cash equivalents |
|
81 |
|
(1,951 |
) |
||
Cash and cash equivalents, beginning of period |
|
1,297 |
|
3,813 |
|
||
Cash and cash equivalents, end of period |
|
$ |
1,378 |
|
$ |
1,862 |
|
Supplemental disclosures of cash flow information: |
|
|
|
|
|
||
Income taxes paid |
|
$ |
569 |
|
$ |
367 |
|
Interest paid |
|
9 |
|
12 |
|
||
Noncash financing activities: |
|
|
|
|
|
||
Capitalized lease obligations |
|
6 |
|
1 |
|
||
Treasury shares issued for: |
|
|
|
|
|
||
Associate stock bonus |
|
26 |
|
25 |
|
||
Shareholder dividend reinvestment |
|
10 |
|
8 |
|
||
Stock compensation grants |
|
2 |
|
1 |
|
See the accompanying Notes to the Consolidated Financial Statements.
6
Aflac Incorporated and Subsidiaries
Consolidated Statements of Comprehensive Income
|
Three Months Ended |
|
Nine Months Ended |
|
|||||||||
|
|
September 30, |
|
September 30, |
|
||||||||
(In millions - Unaudited) |
|
2006 |
|
2005 |
|
2006 |
|
2005 |
|
||||
Net earnings |
|
$ |
367 |
|
$ |
455 |
|
$ |
1,150 |
|
$ |
1,119 |
|
Other comprehensive income (loss) before income taxes: |
|
|
|
|
|
|
|
|
|
||||
Foreign currency translation adjustments: |
|
|
|
|
|
|
|
|
|
||||
Change in unrealized foreign currency translation |
|
(3 |
) |
6 |
|
(8 |
) |
33 |
|
||||
Unrealized gains (losses) on investment securities: |
|
|
|
|
|
|
|
|
|
||||
Unrealized holding gains (losses) arising |
|
1,076 |
|
(1,039 |
) |
(913 |
) |
(239 |
) |
||||
Reclassification adjustment for realized (gains) |
|
(11 |
) |
(140 |
) |
(75 |
) |
(155 |
) |
||||
Minimum pension liability adjustment during period |
|
- |
|
- |
|
- |
|
1 |
|
||||
Total other comprehensive income (loss) |
|
1,062 |
|
(1,173 |
) |
(996 |
) |
(360 |
) |
||||
Income tax expense (benefit) related to items |
|
405 |
|
(376 |
) |
(351 |
) |
(26 |
) |
||||
Other comprehensive income (loss) |
|
657 |
|
(797 |
) |
(645 |
) |
(334 |
) |
||||
Total comprehensive income (loss) |
|
$ |
1,024 |
|
$ |
(342 |
) |
$ |
505 |
|
$ |
785 |
|
See the accompanying Notes to the Consolidated Financial Statements.
7
Aflac Incorporated and Subsidiaries
Notes to the Consolidated Financial Statements
1. BASIS OF PRESENTATION
We prepare our financial statements in accordance with U.S. generally accepted accounting principles (GAAP). These principles are established primarily by the Financial Accounting Standards Board (FASB). The preparation of financial statements in conformity with GAAP requires us to make estimates when recording transactions resulting from business operations based on currently available information. The most significant items on our balance sheet that involve a greater degree of accounting estimates and actuarial determinations subject to changes in the future are the valuation of investments, deferred policy acquisition costs, and liabilities for future policy benefits and unpaid policy claims. These accounting estimates and actuarial determinations are sensitive to market conditions, investment yields, mortality, morbidity, commission and other acquisition expenses, and terminations by policyholders. As additional information becomes available, or actual amounts are determinable, the recorded estimates will be revised and reflected in operating results. Although some variability is inherent in these estimates, we believe the amounts provided are adequate.
The consolidated financial statements include the accounts of the Parent Company, its majority-owned subsidiaries and those entities required to be consolidated under applicable accounting standards. All material intercompany accounts and transactions have been eliminated.
In the opinion of management, the accompanying unaudited consolidated financial statements of Aflac Incorporated and subsidiaries (the Company) contain all adjustments, consisting of normal recurring accruals, which are necessary to fairly present the consolidated balance sheets as of September 30, 2006 and December 31, 2005, the consolidated statements of earnings and comprehensive income for the three- and nine-month periods ended September 30, 2006 and 2005, and the consolidated statements of shareholders equity and cash flows for the nine-month periods ended September 30, 2006 and 2005. Results of operations for interim periods are not necessarily indicative of results for the entire year. As a result, these financial statements should be read in conjunction with the financial statements and notes thereto included in our annual report to shareholders for the year ended December 31, 2005.
New Accounting Pronouncements: In September 2006, the FASB issued Statement of Financial Accounting Standards (SFAS) No. 158, Employers Accounting for Defined Benefit Pension and Other Postretirement Plans, an amendment of FASB Statements No. 87, 88, 106, and 132(R) (SFAS 158). The provisions of SFAS 158 apply to all plan sponsors who offer defined benefit postretirement plans. SFAS 158 requires a plan sponsor to recognize the plans funded status as an asset or liability in its balance sheet, and to measure plan assets and liabilities as of the end of the sponsors fiscal year. It also requires an entity to recognize changes in the funded status of a defined benefit postretirement plan in comprehensive income in the year in which the changes occur. However, SFAS 158 does not change the amount of net periodic benefit cost, or expense, included in net earnings. The recognition and disclosure requirements of SFAS 158 are effective as of the end of the fiscal year ending after December 15, 2006. The measurement date provisions are effective for fiscal years ending after December 15, 2008. Earlier application of the measurement date provisions is encouraged. We do not expect the adoption of this statement to have a significant impact on our financial position or results of operations.
In September 2006, the FASB issued SFAS No. 157, Fair Value Measurements. SFAS 157 defines fair value, establishes a framework for measuring fair value under GAAP, and expands disclosures about fair value measurements. This Statement applies under other accounting pronouncements that require or permit fair value measurements, the Board having previously concluded in those accounting pronouncements that fair value is the relevant measurement attribute. Accordingly, this Statement does not require any new fair value measurements. Where applicable, this Statement simplifies and codifies related guidance within GAAP. SFAS 157 is effective for fiscal years beginning after November 15, 2007 with earlier application encouraged under limited circumstances. We do not expect the adoption of this statement to have a material effect on our financial position or results of operations.
8
In September 2006, the Securities and Exchange Commission (SEC) issued Staff Accounting Bulletin No. 108 (SAB 108). SAB 108 addresses quantifying the financial statement effects of misstatements, specifically, how the effects of prior year uncorrected errors must be considered in quantifying misstatements in current year financials. Under the provisions of SAB 108, a reporting entity must quantify and evaluate errors using a balance sheet approach and an income statement approach. After considering all relevant quantitative and qualitative factors, if either approach results in a misstatement that is material, a reporting entitys financial statements must be adjusted. SAB 108 applies to SEC registrants and is effective for fiscal years ending after November 15, 2006. We are presently evaluating the requirements of SAB 108 and cannot determine its effect on our financial position or results of operations until our evaluation is complete.
In June 2006, the FASB issued FASB Interpretation No. 48 (FIN 48), Accounting for Uncertainty in Income Taxes, an Interpretation of FASB Statement No. 109. The provisions of FIN 48 clarify the accounting for uncertainty in income taxes recognized in an enterprises financial statements in accordance with SFAS No. 109, Accounting for Income Taxes. FIN 48 prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. This Interpretation also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. FIN 48 is effective for fiscal years beginning after December 15, 2006 with earlier application encouraged. We do not expect the adoption of this statement to have a material effect on our financial position or results of operations.
In February 2006, the FASB issued SFAS No. 155, Accounting for Certain Hybrid Financial Instruments, an amendment of FASB Statements No. 133 and 140 (SFAS 155). The provisions of SFAS 155 are effective for all financial instruments acquired or issued after the beginning of the first fiscal year after September 15, 2006. Earlier adoption is permitted. SFAS 155 amends the accounting for hybrid financial instruments and eliminates the exclusion of beneficial interests in securitized financial assets from the guidance under SFAS 133. It also eliminates the prohibition on the type of derivative instruments that qualified special purpose entities may hold under SFAS 140. Furthermore, SFAS 155 clarifies that concentrations of credit risk in the form of subordination are not embedded derivatives. In accordance with the standards early adoption provisions, we adopted the provisions of SFAS 155 on January 1, 2006. The adoption of this standard did not have any impact on our financial position or results of operations.
In December 2004, the FASB issued SFAS No. 123 (revised), Share-Based Payment (SFAS 123R). This standard amends SFAS No. 123, Accounting for Stock-Based Compensation, and supercedes APB Opinion No. 25, Accounting for Stock Issued to Employees, and its related implementation guidance. SFAS 123R establishes the accounting for grants of share-based awards in which an entity exchanges its equity instruments for goods or services. It also addresses transactions in which an entity incurs liabilities in exchange for goods or services that are based on the fair value of the entity's equity instruments or transactions that may be settled by the issuance of those equity instruments. SFAS 123R requires that companies use a fair value method to value share-based awards and recognize the related compensation expense in net earnings. The provisions of SFAS 123R, as amended by the Securities and Exchange Commission, were effective as of the beginning of the first fiscal year after June 15, 2005, although earlier application was encouraged. In accordance with the standard's early adoption provisions, we began accounting for share-based awards using the modified-retrospective application method effective January 1, 2005.
For additional information on new accounting pronouncements and their impact, if any, on our financial position or results of operations, see Note 1 of the Notes to the Consolidated Financial Statements in our annual report to shareholders for the year ended December 31, 2005.
2. BUSINESS SEGMENT INFORMATION
The Company consists of two reportable insurance business segments: Aflac Japan and Aflac U.S., both of which sell individual supplemental health and life insurance. Operating business segments that are not individually reportable are included in the Other business segments category. We do not allocate corporate overhead expenses to business segments.
We evaluate and manage our business segments using a financial performance measure called pretax operating earnings. Our definition of operating earnings excludes the following items from net earnings on an after-tax basis: realized investment gains/losses, the impact from SFAS 133, and
9
nonrecurring items. We then exclude income taxes related to operations to arrive at pretax operating earnings. Information regarding operations by segment follows:
|
Three Months Ended |
|
Nine Months Ended |
|
|||||
|
|
September 30, |
|
September 30, |
|
||||
(In millions) |
|
2006 |
|
2005 |
|
2006 |
|
2005 |
|
Revenues: |
|
|
|
|
|
|
|
|
|
Aflac Japan: |
|
|
|
|
|
|
|
|
|
Earned premiums |
|
$ 2,204 |
|
$ 2,177 |
|
$ 6,558 |
|
$ 6,648 |
|
Net investment income |
|
430 |
|
410 |
|
1,260 |
|
1,232 |
|
Other income |
|
9 |
|
7 |
|
21 |
|
23 |
|
Total Aflac Japan |
|
2,643 |
|
2,594 |
|
7,839 |
|
7,903 |
|
Aflac U.S.: |
|
|
|
|
|
|
|
|
|
Earned premiums |
|
898 |
|
820 |
|
2,642 |
|
2,410 |
|
Net investment income |
|
120 |
|
107 |
|
345 |
|
313 |
|
Other income |
|
3 |
|
2 |
|
7 |
|
7 |
|
Total Aflac U.S. |
|
1,021 |
|
929 |
|
2,994 |
|
2,730 |
|
Other business segments |
|
8 |
|
10 |
|
30 |
|
28 |
|
Total business segment revenues |
|
3,672 |
|
3,533 |
|
10,863 |
|
10,661 |
|
Realized investment gains (losses) |
|
11 |
|
140 |
|
75 |
|
155 |
|
Corporate |
|
11 |
|
35 |
|
62 |
|
54 |
|
Intercompany eliminations |
|
(22 |
) |
(39 |
) |
(71 |
) |
(74 |
) |
Total revenues |
|
$ 3,672 |
|
$ 3,669 |
|
$ 10,929 |
|
$ 10,796 |
|
|
Three Months Ended |
|
Nine Months Ended |
|
|||||
|
|
September 30, |
|
September 30, |
|
||||
(In millions) |
|
2006 |
|
2005 |
|
2006 |
|
2005 |
|
Pretax earnings: |
|
|
|
|
|
|
|
|
|
Aflac Japan |
|
$ 407 |
|
$ 392 |
|
$ 1,264 |
|
$ 1,178 |
* |
Aflac U.S. |
|
162 |
|
133 |
|
459 |
|
396 |
|
Other business segments |
|
- |
|
(3 |
) |
2 |
|
(1 |
) |
Total business segments |
|
569 |
|
522 |
|
1,725 |
|
1,573 |
|
Interest expense, noninsurance operations |
|
(3 |
) |
(5 |
) |
(12 |
) |
(15 |
) |
Corporate and eliminations |
|
(15 |
) |
(9 |
) |
(32 |
) |
(34 |
) |
Pretax operating earnings |
|
551 |
|
508 |
|
1,681 |
|
1,524 |
|
Realized investment gains (losses) |
|
11 |
|
140 |
|
75 |
|
155 |
|
Impact from SFAS 133 |
|
(5 |
) |
(3 |
) |
- |
|
(12 |
) |
Total earnings before income taxes |
|
$ 557 |
|
$ 645 |
|
$ 1,756 |
|
$ 1,667 |
|
Income taxes applicable to pretax operating earnings |
|
$ 188 |
|
$ 175 |
|
$ 579 |
|
$ 530 |
|
Effect of foreign currency
translation on |
|
(6 |
) |
(2 |
) |
(39 |
) |
6 |
|
*Includes a charge of $18 related to the write-down of previously capitalized systems development costs for Aflac Japans administration system.
10
Assets were as follows:
|
September 30, |
|
December 31, |
|
|||||
(In millions) |
|
2006 |
|
2005 |
|
||||
Assets: |
|
|
|
|
|
||||
Aflac Japan |
|
|
$ 47,444 |
|
|
|
$ 46,200 |
|
|
Aflac U.S. |
|
|
10,070 |
|
|
|
9,547 |
|
|
Other business segments |
|
|
94 |
|
|
|
90 |
|
|
Total business segments |
|
|
57,608 |
|
|
|
55,837 |
|
|
Corporate |
|
|
9,686 |
|
|
|
9,559 |
|
|
Intercompany eliminations |
|
|
(8,941 |
) |
|
|
(9,035 |
) |
|
Total assets |
|
|
$ 58,353 |
|
|
|
$ 56,361 |
|
|
3. INVESTMENTS
Realized Investment Gains and Losses
During the quarter ended September 30, 2006, we realized pretax investment gains of $11 million (after-tax, $7 million, or $.01 per diluted share) primarily as a result of securities sales. For the nine months ended September 30, 2006, we realized pretax investment gains of $75 million (after-tax $47 million, or $.10 per diluted share) as a result of securities sales and bond swaps. The bond swaps executed during the first and second quarters of 2006 conclude the bond-swap program that we began in the third quarter of 2005 to take advantage of tax loss carryforwards. Impairment charges were immaterial during the nine months ended September 30, 2006.
For the quarter ended September 30, 2005, we realized pretax investment gains of $140 million (after-tax, $89 million, or $.18 per diluted share) primarily as a result of the execution of bond swaps that enabled the Company to take advantage of tax loss carryforwards. For the nine months ended September 30, 2005, we realized pretax investment gains of $155 million (after-tax, $99 million, or $.19 per diluted share). Impairment charges were immaterial during the nine months ended September 30, 2005.
Unrealized Investment Gains and Losses
The net effect on shareholders equity of unrealized gains and losses from investment securities at the following dates was:
|
September 30, |
|
December 31, |
|
|||||
(In millions) |
|
2006 |
|
2005 |
|
||||
Unrealized gains on securities available-for-sale |
|
|
$ 1,502 |
|
|
|
$ 2,452 |
|
|
Unamortized unrealized gains
on securities |
|
|
393 |
|
|
|
430 |
|
|
Deferred income taxes |
|
|
(620 |
) |
|
|
(965 |
) |
|
Shareholders equity, net
unrealized gains on |
|
|
$ 1,275 |
|
|
|
$ 1,917 |
|
|
The decrease in unrealized gains on available-for-sale securities primarily resulted from a rising interest rate environment.
11
Special Purpose and Variable Interest Entities
As part of our investment activities, we own investments in qualified special purpose entities (QSPEs). At September 30, 2006, available-for-sale QSPEs totaled $2.2 billion at fair value ($2.3 billion at amortized cost, or 4.7% of total debt securities), compared with $2.2 billion at fair value ($2.3 billion at amortized cost, or 5.0% of total debt securities) at December 31, 2005. We have no equity interests in any of the QSPEs, nor do we have control over these entities. Therefore, our loss exposure is limited to the cost of our investment.
We also own yen-denominated investments in variable interest entities (VIEs) totaling $1.8 billion at fair value ($1.9 billion at amortized cost, or 4.0% of total debt securities) at September 30, 2006. We are the primary beneficiary of VIEs totaling $1.5 billion at fair value ($1.7 billion at amortized cost) and have consolidated our interests in these VIEs in accordance with FASB Interpretation No. 46 (revised December 2003), Consolidation of Variable Interest Entities. The activities of these VIEs are limited to holding debt securities and utilizing the cash flows from the debt securities to service our investments therein. The terms of the debt securities mirror the terms of the notes held by Aflac. The consolidation of these investments does not impact our financial position or results of operations. We also have interests in VIEs that we are not required to consolidate totaling $239 million at fair value ($241 million at amortized cost) as of September 30, 2006. The loss on any of our VIE investments would be limited to its cost.
Security Lending
We lend fixed-maturity securities to financial institutions in short-term security lending transactions. These securities continue to be carried as investment assets on our balance sheet during the term of the loans and are not recorded as sales. We receive cash or other securities as collateral for such loans. These short-term security lending arrangements increase investment income with minimal risk. Our security lending policy requires that the fair value of the securities and/or cash received as collateral be 102% or more of the fair value of the loaned securities. At September 30, 2006, we had security loans outstanding with a fair value of $425 million, and we held cash in the amount of $440 million as collateral for these loaned securities. At December 31, 2005, we had security loans outstanding with a fair value of $605 million, and we held cash in the amount of $622 million as collateral for these loaned securities. For additional information, see Notes 1 and 3 of the Notes to the Consolidated Financial Statements in our annual report to shareholders for the year ended December 31, 2005.
4. FINANCIAL INSTRUMENTS
We have only limited activity with derivative financial instruments. We do not use them for trading purposes, nor do we engage in leveraged derivative transactions.
We have outstanding cross-currency swap agreements related to the $450 million senior notes (see Note 5). We have designated the foreign currency component of these cross-currency swaps as a hedge of the foreign currency exposure of our investment in Aflac Japan. The notional amounts and terms of the swaps match the principal amount and terms of the senior notes.
12
The components of the fair value of the cross-currency swaps were reflected as an asset or (liability) in the balance sheet as follows:
|
September 30, |
|
December 31, |
|
|||||
(In millions) |
|
2006 |
|
2005 |
|
||||
Interest rate component |
|
|
$ 6 |
|
|
|
$ 6 |
|
|
Foreign currency component |
|
|
(21 |
) |
|
|
(22 |
) |
|
Accrued interest component |
|
|
10 |
|
|
|
4 |
|
|
Total fair value of cross-currency swaps |
|
|
$ (5 |
) |
|
|
$ (12 |
) |
|
The following is a reconciliation of the foreign currency component of the cross-currency swaps as included in accumulated other comprehensive income for the nine-month periods ended September 30.
(In millions) |
|
2006 |
|
2005 |
|
||||
Balance, beginning of period |
|
|
$ (22 |
) |
|
|
$ (91 |
) |
|
Increase (decrease) in fair value of cross-currency swaps |
|
|
7 |
|
|
|
44 |
|
|
Interest rate component not
qualifying for hedge accounting |
|
|
(6 |
) |
|
|
7 |
|
|
Balance, end of period |
|
|
$ (21 |
) |
|
|
$ (40 |
) |
|
We have also entered into interest rate swap agreements related to the 20 billion yen variable interest rate Uridashi notes (see Note 5). By entering into these contracts, we have been able to lock-in our interest expense at 1.52% in yen. We have designated these interest rate swaps as a hedge of the variability in our interest cash flows associated with the variable interest rate Uridashi notes. The notional amounts and terms of the swaps match the principal amount and terms of the variable interest rate Uridashi notes. The swaps had no value at inception. Changes in the fair value of the swap contracts are recorded in other comprehensive income. The fair value of these swaps and related changes in fair value were immaterial during the three-month period ended September 30, 2006.
5. NOTES PAYABLE
A summary of notes payable follows:
|
September 30, |
|
December 31, |
|
|||||
(In millions) |
|
2006 |
|
2005 |
|
||||
Yen-denominated Uridashi notes: |
|
|
|
|
|
||||
1.52% notes due September 2011 (principal amount |
|
|
$ 127 |
|
|
|
$ - |
|
|
2.26% notes due September 2016 (principal amount |
|
|
85 |
|
|
|
- |
|
|
Variable interest rate notes due September 2011 (.71% at September 2006, principal amount 20 billion yen) |
|
|
170 |
|
|
|
- |
|
|
Yen-denominated Samurai notes: |
|
|
|
|
|
|
|
|
|
.87% notes paid June 2006 (principal amount 40 billion yen) |
|
|
- |
|
|
|
339 |
|
|
.96% notes due June 2007 (principal amount 30 billion yen) |
|
|
254 |
|
|
|
254 |
|
|
.71% notes due July 2010 (principal amount 40 billion yen) |
|
|
339 |
|
|
|
339 |
|
|
6.50% senior notes due April 2009 |
|
|
450 |
|
|
|
450 |
|
|
Capitalized lease obligations payable through 2012 |
|
|
14 |
|
|
|
13 |
|
|
Total notes payable |
|
|
$ 1,439 |
|
|
|
$ 1,395 |
|
|
13
In August 2006, the Parent Company filed a Shelf Registration Statement with Japanese regulatory authorities to issue up to 100 billion yen of yen-denominated Uridashi notes in Japan. In September 2006, the Parent Company issued three tranches of Uridashi notes totaling 45 billion yen. The first tranche totaled 15 billion yen and has a five-year maturity. The second tranche totaled 10 billion yen and has a 10-year maturity. The third tranche totaled 20 billion yen and has a five-year maturity and a variable interest coupon of six-month yen LIBOR plus a spread. We have entered into interest rate swaps related to the 20 billion yen variable interest rate notes (see Note 4). Each tranche of Uridashi notes pays interest semiannually, may only be redeemed prior to maturity upon the occurrence of a tax event as specified in the respective bond agreement and is not available to U.S. persons. If issued, the 55 billion yen of Uridashi notes remaining under the August 2006 Shelf Registration Statement will not be available to U.S. persons.
In 2001, 2002, and 2005 the Parent Company issued yen-denominated Samurai notes, each with five-year maturities. Each series of Samurai notes pays interest semiannually, may only be redeemed prior to maturity upon the occurrence of a tax event as specified in the respective bond agreement and is not available to U.S. persons. In June 2006, we paid in full the .87% Samurai notes issued in 2001.
For our yen-denominated loans, the principal amount as stated in dollar terms will fluctuate from period to period due to changes in the yen/dollar exchange rate. We have designated all of our yen-denominated notes payable as a hedge of the foreign currency exposure of our investment in Aflac Japan. We have also designated the interest rate swaps on our variable interest rate Uridashi notes as a hedge of the variability in our interest cash flows associated with these notes.
The Parent Company filed a Shelf Registration Statement with Japanese regulatory authorities in February 2006 to issue up to 100 billion yen of yen-denominated Samurai notes in Japan. If issued, these securities will not be available to U.S. persons.
In 1999, we issued $450 million of senior notes. These notes pay interest semiannually and are redeemable at our option at any time with a redemption price equal to the principal amount of the notes redeemed plus a make-whole premium. We have entered into cross-currency swaps related to these notes (see Note 4).
We were in compliance with all of the covenants of our notes payable at September 30, 2006. No events of default or defaults occurred during the nine months ended September 30, 2006.
14
6. SHAREHOLDERS EQUITY
The following table is a reconciliation of the number of shares of the Companys common stock for the nine-month periods ended September 30.
(In thousands of shares) |
|
2006 |
|
2005 |
|
Common stock - issued: |
|
|
|
|
|
Balance, beginning of period |
|
654,522 |
|
652,628 |
|
Exercise of stock options |
|
844 |
|
1,237 |
|
Balance, end of period |
|
655,366 |
|
653,865 |
|
Treasury stock: |
|
|
|
|
|
Balance, beginning of period |
|
155,628 |
|
149,020 |
|
Purchases of treasury stock: |
|
|
|
|
|
Open market |
|
7,131 |
|
7,582 |
|
Other |
|
2 |
|
156 |
|
Dispositions of treasury stock: |
|
|
|
|
|
Shares issued to AFL Stock Plan |
|
(1,093 |
) |
(1,148 |
) |
Exercise of stock options |
|
(884 |
) |
(1,767 |
) |
Other |
|
(84 |
) |
(261 |
) |
Balance, end of period |
|
160,700 |
|
153,582 |
|
Shares outstanding, end of period |
|
494,666 |
|
500,283 |
|
We exclude outstanding share-based awards from the calculation of weighted-average shares used in the computation of basic earnings per share. For the quarter ended September 30, 2006, stock options to purchase approximately 2.2 million shares, weighted-average basis, were considered to be anti-dilutive and were excluded from the calculation of diluted earnings per share, compared with 1.8 million for the quarter ended September 30, 2005. For the nine months ended September 30, 2006, stock options to purchase approximately 1.6 million shares, weighted-average basis, were considered to be anti-dilutive and were excluded from the calculation of diluted earnings per share, compared with 2.9 million for the nine month period a year ago.
In February 2006, the board of directors authorized the purchase of 30 million shares of our common stock. As of September 30, 2006, approximately 40 million shares were available for purchase under our share repurchase programs.
7. SHARE-BASED TRANSACTIONS
The Company has two long-term incentive compensation plans. The first is a stock option plan, which allows grants for both incentive stock options (ISOs) to employees and non-qualifying stock options (NQSOs) to employees and non-employee directors. The options have a term of 10 years and time-based vesting conditions. The strike price of options granted under this plan is equal to the fair market value of a share of our common stock at the date of grant. At September 30, 2006, approximately 760 thousand shares were available for future grants under this plan.
The second long-term incentive compensation plan allows awards to Company employees for ISOs, NQSOs, restricted stock, restricted stock units, and stock appreciation rights. Non-employee directors are eligible for grants of NQSOs, restricted stock, and stock appreciation rights. Generally, the awards vest based upon time-based conditions or time-and-performance-based conditions. Performance-based vesting conditions generally include the attainment of goals related to Company financial performance. As of September 30, 2006, the only performance-based awards issued and outstanding were restricted stock awards. At September 30, 2006, approximately 24 million shares were available for future grants under this plan.
15
Share-based awards granted to U.S.-based grantees are settled upon exercise with authorized but unissued Company stock, while those issued to Japan-based grantees are settled upon exercise with treasury shares. We estimate the fair value of each stock option granted using the Black-Scholes-Merton multiple option approach. The value of restricted stock awards is based on the fair market value of our common stock at the date of grant.
We adopted SFAS 123R to account for share-based awards effective January 1, 2005. In accordance with the modified-retrospective application method, we adjusted previously reported results to reflect the effect of expensing share-based awards.
The following table provides information on stock options outstanding and exercisable.
|
Stock |
|
Weighted-Average |
|
|||
|
|
Option |
|
Exercise Price |
|
||
(In thousands of shares) |
|
Shares |
|
Per Share |
|
||
Outstanding at September 30, 2006 |
|
20,088 |
|
|
$ 29.55 |
|
|
Exercisable at September 30, 2006 |
|
16,730 |
|
|
26.95 |
|
|
As of September 30, 2006, the aggregate intrinsic value of stock options outstanding was $328 million, with a weighted-average remaining term of 5.4 years. The aggregate intrinsic value of stock options exercisable at that same date was $316 million, with a weighted-average remaining term of 4.6 years. We received $26 million and $41 million in cash from the exercise of stock options during the nine-month periods ended September 30, 2006 and 2005, respectively. The tax benefit realized as a result of stock option exercises was $12 million for the first nine months of 2006, compared with $27 million in the first nine months of 2005.
As of September 30, 2006, total compensation cost not yet recognized in our financial statements related to restricted stock awards was $18 million, of which $8 million (309 thousand shares) was related to share-based awards with a performance-based vesting condition. We expect to recognize these amounts over a weighted-average period of approximately 2.0 years. There are no other contractual terms covering restricted stock awards once vested.
For additional information on our long-term share-based compensation plans and the types of share-based awards, see Note 9 of the Notes to the Consolidated Financial Statements included in our annual report to shareholders for the year ended December 31, 2005.
16
8. BENEFIT PLANS
Our basic employee defined-benefit pension plans cover substantially all of our full-time employees in the United States and Japan. The components of retirement expense for the Japanese and U.S. pension plans were as follows:
|
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
|
|||||||||||||||||||||
|
|
2006 |
|
2005 |
|
2006 |
|
2005 |
|
||||||||||||||||
(In millions) |
|
Japan |
|
U.S. |
|
Japan |
|
U.S. |
|
Japan |
|
U.S. |
|
Japan |
|
U.S. |
|
||||||||
Components of net periodic benefit cost: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Service cost |
|
|
$ 2 |
|
|
$ 2 |
|
|
$ 2 |
|
|
$ 1 |
|
|
$ 6 |
|
|
$ 7 |
|
|
$ 4 |
|
|
$ 5 |
|
Interest cost |
|
|
1 |
|
|
2 |
|
|
1 |
|
|
2 |
|
|
2 |
|
|
7 |
|
|
2 |
|
|
6 |
|
Expected return on |
|
|
(1 |
) |
|
(2 |
) |
|
(1 |
) |
|
(1 |
) |
|
(1 |
) |
|
(6 |
) |
|
(1 |
) |
|
(4 |
) |
Amortization of net actuarial loss |
|
|
1 |
|
|
1 |
|
|
1 |
|
|
1 |
|
|
2 |
|
|
3 |
|
|
2 |
|
|
2 |
|
Net periodic benefit cost |
|
|
$ 3 |
|
|
$ 3 |
|
|
$ 3 |
|
|
$ 3 |
|
|
$ 9 |
|
|
$ 11 |
|
|
$ 7 |
|
|
$ 9 |
|
As of September 30, 2006, approximately $17 million (using the September 30, 2006 exchange rate) had been contributed to the Japanese pension plan. As of September 30, 2006, $20 million had been contributed to the U.S. pension plan.
For additional information regarding our Japanese and U.S. pension plans, see Note 11 of the Notes to the Consolidated Financial Statements in our annual report to shareholders for the year ended December 31, 2005.
9. COMMITMENTS AND CONTINGENT LIABILITIES
Commitments: We have employee benefit plans that provide pension and various post-retirement benefits. For additional information regarding our benefit plans, see Note 11 of the Notes to the Consolidated Financial Statements in our annual report to shareholders for the year ended December 31, 2005.
We lease office space and equipment under various agreements that expire in various years through 2021. For further information regarding lease commitments, see Note 12 of the Notes to the Consolidated Financial Statements in our annual report to shareholders for the year ended December 31, 2005.
In 2005, we announced a multi-year building project for additional office space in Columbus, Georgia. The initial phase is to be completed in 2007 and is expected to cost approximately $26 million.
We have entered into an outsourcing agreement with IBM to provide mainframe computer operations and support for our Japanese operations. The agreement has a term of 10 years with an aggregate cost of 28.2 billion yen ($240 million using the September 30, 2006 exchange rate).
Litigation: We are a defendant in various lawsuits considered to be in the normal course of business. Some of this litigation is pending in states where large punitive damages bearing little relation to the actual damages sustained by plaintiffs have been awarded against other companies,
17
including insurers, in recent years. Although the final results of any litigation cannot be predicted with certainty, we believe the outcome of pending litigation will not have a material adverse effect on our financial position, results of operations, or cash flows.
18
REVIEW BY INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The September 30, 2006, and 2005, financial statements included in this filing have been reviewed by KPMG LLP, an independent registered public accounting firm, in accordance with established professional standards and procedures for such a review.
The report of KPMG LLP commenting upon its review is included on Page 20.
19
Report of Independent Registered Public Accounting Firm
The shareholders and board of directors of Aflac Incorporated:
We have reviewed the consolidated balance sheet of Aflac Incorporated and subsidiaries as of September 30, 2006, and the related consolidated statements of earnings and comprehensive income for the three-month and nine-month periods ended September 30, 2006, and 2005, and the consolidated statements of shareholders equity and cash flows for the nine-month periods ended September 30, 2006, and 2005. These consolidated financial statements are the responsibility of the Companys management.
We conducted our reviews in accordance with the standards of the Public Company Accounting Oversight Board (United States). A review of interim financial information consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the standards of the Public Company Accounting Oversight Board (United States), the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.
Based on our reviews, we are not aware of any material modifications that should be made to the consolidated financial statements referred to above for them to be in conformity with U.S. generally accepted accounting principles.
We have previously audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the accompanying consolidated balance sheet of Aflac Incorporated and subsidiaries as of December 31, 2005, and the related consolidated statements of earnings, shareholders equity, cash flows and comprehensive income for the year then ended (not presented herein); and in our report dated February 28, 2006, we expressed an unqualified opinion on those consolidated financial statements.
As discussed in Notes 1 and 7 to the consolidated financial statements, the Company adopted Statement of Financial Accounting Standards No. 123 (revised 2004), Share-Based Payment, to account for stock options and other share-based transactions, effective January 1, 2005.
|
|
|
|
|
|
|
|
|
Atlanta, Georgia |
|
|
November 6, 2006 |
|
|
20
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations.
The Private Securities Litigation Reform Act of 1995 provides a safe harbor to encourage companies to provide prospective information, so long as those informational statements are identified as forward-looking and are accompanied by meaningful cautionary statements identifying important factors that could cause actual results to differ materially from those included in the forward-looking statements. We desire to take advantage of these provisions. This report contains cautionary statements identifying important factors that could cause actual results to differ materially from those projected herein, and in any other statements made by Company officials in communications with the financial community and contained in documents filed with the Securities and Exchange Commission (SEC). Forward-looking statements are not based on historical information and relate to future operations, strategies, financial results or other developments. Furthermore, forward-looking information is subject to numerous assumptions, risks, and uncertainties. In particular, statements containing words such as expect, anticipate, believe, goal, objective, may, should, estimate, intends, projects, will, assumes, potential, target, or similar words as well as specific projections of future results, generally qualify as forward-looking. Aflac undertakes no obligation to update such forward-looking statements.
We caution readers that the following factors, in addition to other factors mentioned from time to time could cause actual results to differ materially from those contemplated by the forward-looking statements:
· legislative and regulatory developments
· assessments for insurance company insolvencies
· competitive conditions in the United States and Japan
· new product development and customer response to new products and new marketing initiatives
· ability to attract and retain qualified sales associates and employees
· ability to repatriate profits from Japan
· changes in U.S. and/or Japanese tax laws or accounting requirements
· credit and other risks associated with Aflacs investment activities
· significant changes in investment yield rates
· fluctuations in foreign currency exchange rates
· deviations in actual experience from pricing and reserving assumptions including, but not limited to, morbidity, mortality, persistency, expenses, and investment yields
· level and outcome of litigation
· downgrades in the Companys credit rating
· changes in rating agency policies or practices
· subsidiarys ability to pay dividends to Parent Company
· ineffectiveness of hedging strategies
· catastrophic events
· general economic conditions in the United States and Japan
21
Aflac Incorporated (the Parent Company) and its subsidiaries (the Company) primarily sell supplemental health and life insurance in the United States and Japan. The Companys insurance business is marketed and administered through American Family Life Assurance Company of Columbus (Aflac), which operates in the United States (Aflac U.S.) and as a branch in Japan (Aflac Japan). Most of Aflacs policies are individually underwritten and marketed through independent agents. Our insurance operations in the United States and our branch in Japan service the two markets for our insurance business.
Managements Discussion and Analysis of Financial Condition and Results of Operations (MD&A) is intended to inform the reader about matters affecting the financial condition and results of operations of Aflac Incorporated and its subsidiaries for the period from December 31, 2005, to September 30, 2006. As a result, the following discussion should be read in conjunction with the consolidated financial statements and notes that are included in our annual report to shareholders for the year ended December 31, 2005.
This MD&A is divided into four primary sections. In the first section, we discuss our critical accounting estimates. We then follow with a discussion of the results of our operations on a consolidated basis and by segment. The third section presents an analysis of our financial condition as well as a discussion of market risks of financial instruments. We conclude by addressing the availability of capital and the sources and uses of cash in the Capital Resources and Liquidity section.
We prepare our financial statements in accordance with U.S. generally accepted accounting principles (GAAP). The preparation of financial statements in conformity with GAAP requires us to make estimates based on currently available information when recording transactions resulting from business operations. The estimates that we deem to be most critical to an understanding of Aflacs results of operations and financial condition are those related to investments, deferred policy acquisition costs and policy liabilities. The preparation and evaluation of these critical accounting estimates involve the use of various assumptions developed from managements analyses and judgments. The application of these critical accounting estimates determines the values at which 95% of our assets and 85% of our liabilities are reported and thus have a direct effect on net earnings and shareholders equity. Subsequent experience or use of other assumptions could produce significantly different results. There have been no changes in the items that we have identified as critical accounting estimates during the nine months ended September 30, 2006. For additional information, see the Critical Accounting Estimates section of MD&A included in our annual report to shareholders for the year ended December 31, 2005.
For information on new accounting pronouncements and the impact, if any, on our financial position or results of operations, see Note 1 of the Notes to the Consolidated Financial Statements.
22
RESULTS OF OPERATIONS
The following table is a presentation of items impacting net earnings and net earnings per diluted share.
Items Impacting Net Earnings
|
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
|
|||||||||||||
|
|
2006 |
|
2005 |
|
2006 |
|
2005 |
|
2006 |
|
2005 |
|
2006 |
|
2005 |
|
|
|
In millions |
|
Per Diluted Share |
|
In millions |
|
Per Diluted Share |
|
||||||||
Net earnings |
|
$ 367 |
|
$ 455 |
|
$ .73 |
|
$ .90 |
|
$ 1,150 |
|
$ 1,119 |
|
$ 2.29 |
|
$ 2.20 |
|
Items impacting net earnings, net of tax: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Realized investment gains (losses) |
|
7 |
|
89 |
|
.01 |
|
.18 |
|
47 |
|
99 |
|
.10 |
|
.19 |
|
Impact from SFAS 133 |
|
(3 |
) |
(1 |
) |
- |
|
(.01 |
) |
- |
|
(8 |
) |
- |
|
(.02 |
) |
Release of deferred tax asset valuation allowance |
|
- |
|
34 |
|
- |
|
.07 |
|
- |
|
34 |
|
- |
|
.07 |
|
Realized Investment Gains and Losses
Our investment strategy is to invest in fixed-income securities in order to provide a reliable stream of investment income, which is one of the drivers of the Companys profitability. We do not purchase securities with the intent of generating capital gains or losses. However, investment gains and losses may be realized as a result of changes in the financial markets and the creditworthiness of specific issuers and/or tax planning strategies. The realization of investment gains and losses is independent of the underwriting and administration of our insurance products, which are the principal drivers of our profitability. Realized investment gains in the first nine months of 2006 primarily resulted from securities sales and bond swaps. The bond swaps executed during the first and second quarters of 2006 conclude the bond-swap program that we began in the third quarter of 2005 to take advantage of tax loss carryforwards. Realized investment gains in the first nine months of 2005 primarily resulted from our bond-swap program and sales transactions in the normal course of business.
Impact from SFAS 133
We entered into cross-currency swap agreements to effectively convert our dollar-denominated senior notes, which mature in 2009, into a yen-denominated obligation (see Notes 4 and 5 of the Notes to the Consolidated Financial Statements). The effect of issuing fixed-rate, dollar-denominated debt and swapping it into fixed-rate, yen-denominated debt has the same economic impact on Aflac as if we had issued yen-denominated debt of a like amount. However, the accounting treatment for cross-currency swaps is different from issuing yen-denominated Samurai and Uridashi notes. Statement of Financial Accounting Standards No. 133, Accounting for Derivative Instruments and Hedging Activities, as amended (SFAS 133), requires that the change in the fair value of the interest rate component of the cross-currency swap, which does not qualify for hedge accounting, be reflected in net earnings (other income). This change in fair value is determined by relative dollar and yen interest rates and has no cash impact on our results of operations. At maturity, the swaps fair value and their initial contract fair value will be equal, and the cumulative impact of gains and losses from the changes in fair value of the interest component will be zero. We have the ability and intent to retain the cross-currency swaps until their maturity. The impact from SFAS 133 includes the change in fair value of the interest rate component of the cross-currency swaps, which does not qualify for hedge accounting.
23
During the third quarter of 2006, we entered into interest rate swap agreements related to the 20 billion yen variable interest rate Uridashi notes (see Note 5). By entering into these contracts, we have been able to lock-in our interest expense at 1.52% in yen. We have designated these interest rate swaps as a hedge of the variability in our interest cash flows associated with the variable interest rate Uridashi notes. The notional amounts and terms of the swaps match the principal amount and terms of the variable interest rate Uridashi notes, and the swaps had no value at inception. Changes in the fair value of the swap contracts are recorded in other comprehensive income. The fair value of these swaps and related changes in fair value were immaterial during the three-month period ended September 30, 2006.
We have issued yen-denominated Samurai and Uridashi notes. We have designated these notes as a hedge of our investment in Aflac Japan. If the value of these yen-denominated notes and the notional amounts of the cross-currency swaps exceed our investment in Aflac Japan, we would be required to recognize the foreign currency effect on the excess, or ineffective portion, in net earnings (other income). The ineffective portion would be included in the impact from SFAS 133. These hedges were effective during the nine-month period ended September 30, 2006; therefore, there was no impact on net earnings. See Note 4 of the Notes to the Consolidated Financial Statements and Note 1 of the Notes to the Consolidated Financial Statements in our annual report to shareholders for the year ended December 31, 2005, for additional information.
Nonrecurring Items
During the third quarter of 2005, we received regulatory approval for a change in the allocation of expenses incurred by the Parent Company. The change in the allocation of expenses under the management fee agreement between Aflac and the Parent Company allows it to take advantage of its nonlife operating losses. As a result, we recognized a benefit of $34 million, or $.07 per diluted share due to the release of a valuation allowance for deferred tax assets related to the Parent Companys nonlife operating losses.
Foreign Currency Translation
Aflac Japans premiums and most of its investment income are received in yen. Claims and expenses are paid in yen, and we primarily purchase yen-denominated assets to support yen-denominated policy liabilities. These and other yen-denominated financial statement items are translated into dollars for financial reporting purposes. We translate Aflac Japans yen-denominated income statement into dollars using an average exchange rate for the reporting period, and we translate its yen-denominated balance sheet using the exchange rate at the end of the period. However, it is important to distinguish between translating and converting foreign currency. Except for a limited number of transactions, we do not actually convert yen into dollars.
Due to the size of Aflac Japan, where our functional currency is the Japanese yen, fluctuations in the yen/dollar exchange rate can have a significant effect on our reported results. In periods when the yen weakens, translating yen into dollars causes fewer dollars to be reported. When the yen strengthens, translating yen into dollars causes more dollars to be reported. Consequently, yen weakening has the effect of suppressing current period results in relation to the comparable prior period, while yen strengthening has the effect of magnifying current period results in relation to the comparable prior period. As a result, we view foreign currency translation as a financial reporting issue for Aflac and not an economic event to our Company or shareholders. Because changes in
24
exchange rates distort the growth rates of our operations, management evaluates Aflacs financial performance excluding the impact of foreign currency translation.
Income Taxes
Our combined U.S. and Japanese effective income tax rate on net earnings was 34.5% for the nine-month period ended September 30, 2006, compared with 32.9% for the same period in 2005. The lower effective tax rate in 2005 is due to the release of a $34 million valuation allowance for deferred tax assets recorded in the third quarter of 2005 (see Nonrecurring Items above).
Earnings Guidance
We communicate earnings guidance in this report based on the growth in net earnings per diluted share. However, certain items that cannot be predicted or that are outside of managements control may have a significant impact on actual results. Therefore, our comparison of net earnings includes certain assumptions to reflect the limitations that are inherent in projections of net earnings. In comparing period-over-period results, we exclude the effect of realized investment gains and losses, the impact from SFAS 133 and nonrecurring items. We also assume no impact from foreign currency translation on the Aflac Japan segment and the Parent Companys yen-denominated interest expense for a given period in relation to the prior period.
Subject to the preceding assumptions, our objective for 2006 is to achieve net earnings per diluted share of at least $2.92, an increase of 15.0% over 2005. If we achieve this objective, the following table shows the likely results for 2006 net earnings per diluted share, including the impact of foreign currency translation using various yen/dollar exchange rate scenarios.
2006 Net Earnings Per Share (EPS) Scenarios*
Weighted-Average |
|
Net Earnings Per |
|
% Growth |
|
Yen Impact |
|
||||
100.00 |
|
|
$ |
3.07 |
|
20.9 |
% |
|
$ .15 |
|
|
105.00 |
|
|
|
2.99 |
|
17.7 |
|
|
.07 |
|
|
109.88 |
** |
|
|
2.92 |
|
15.0 |
|
|
- |
|
|
115.00 |
|
|
|
2.86 |
|
12.6 |
|
|
(.06 |
) |
|
120.00 |
|
|
|
2.81 |
|
10.6 |
|
|
(.11 |
) |
|
* Excludes realized investment gains/losses, impact from SFAS 133 and nonrecurring items in 2006 and 2005; and assumes no impact from currency translation in 2006
** Actual 2005 weighted-average exchange rate
Our objective for 2007 is to increase net earnings per diluted share by 15% to 16%, on the basis described above.
INSURANCE OPERATIONS
Aflacs insurance business consists of two segments: Aflac Japan and Aflac U.S. Aflac Japan, which operates as a branch of Aflac, is the principal contributor to consolidated earnings. GAAP financial reporting requires that a company report financial and descriptive information about operating segments in its annual and interim period financial statements. Furthermore, we are required to report a measure of segment profit or loss, certain revenue and expense items, and segment assets.
25
We measure and evaluate our insurance segments financial performance using operating earnings on a pretax basis. We define segment operating earnings as the profits we derive from our operations before realized investment gains and losses, the impact from SFAS 133, and nonrecurring items. We believe that an analysis of segment pretax operating earnings is vitally important to an understanding of the underlying profitability drivers and trends of our insurance business. Furthermore, because a significant portion of our business is conducted in Japan, we believe it is equally important to understand the impact of translating Japanese yen into U.S. dollars.
We evaluate our sales efforts using new annualized premium sales, an industry operating measure. Total new annualized premium sales, which include new sales and the incremental increase in premiums due to conversions, represent the premiums that we would collect over a 12-month period, assuming the policies remain in force. Premium income, or earned premiums, is a financial performance measure that reflects collected or due premiums that have been earned ratably on policies in force during the reporting period.
26
AFLAC JAPAN
Aflac Japan Pretax Operating Earnings
Changes in Aflac Japans pretax operating earnings and profit margins are primarily affected by morbidity, mortality, expenses, persistency, and investment yields. The following table presents a summary of operating results for Aflac Japan.
Aflac Japan Summary of Operating Results
|
Three Months Ended |
|
Nine Months Ended |
|
|||||
(In millions) |
|
2006 |
|
2005 |
|
2006 |
|
2005 |
|
Premium income |
|
$ 2,204 |
|
$ 2,177 |
|
$ 6,558 |
|
$ 6,648 |
|
Net investment income: |
|
|
|
|
|
|
|
|
|
Yen-denominated investment income |
|
271 |
|
279 |
|
796 |
|
852 |
|
Dollar-denominated investment income |
|
159 |
|
131 |
|
464 |
|
380 |
|
Net investment income |
|
430 |
|
410 |
|
1,260 |
|
1,232 |
|
Other income |
|
9 |
|
7 |
|
21 |
|
23 |
|
Total operating revenues |
|
2,643 |
|
2,594 |
|
7,839 |
|
7,903 |
|
Benefits and claims |
|
1,746 |
|
1,728 |
|
5,120 |
|
5,249 |
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
Amortization of deferred policy acquisition costs |
|
70 |
|
69 |
|
212 |
|
213 |
|
Insurance commissions |
|
212 |
|
214 |
|
645 |
|
681 |
|
Insurance and other expenses |
|
208 |
|
191 |
|
598 |
|
582 |
|
Total operating expenses |
|
490 |
|
474 |
|
1,455 |
|
1,476 |
|
Total benefits and expenses |
|
2,236 |
|
2,202 |
|
6,575 |
|
6,725 |
|
Pretax operating earnings* |
|
$ 407 |
|
$ 392 |
|
$ 1,264 |
|
$ 1,178 |
|
Weighted-average yen/dollar exchange rates |
|
116.17 |
|
111.30 |
|
115.82 |
|
107.79 |
|
|
In Dollars |
|
In Yen |
|
|||||||||||||
Percentage change over |
|
Three Months |
|
Nine Months |
|
Three Months |
|
Nine Months |
|
||||||||
previous period: |
|
2006 |
|
2005 |
|
2006 |
|
2005 |
|
2006 |
|
2005 |
|
2006 |
|
2005 |
|
Premium income |
|
1.2 |
% |
4.8 |
% |
(1.4 |
)% |
7.5 |
% |
5.8 |
% |
6.1 |
% |
6.0 |
% |
6.4 |
% |
Net investment income |
|
4.9 |
|
5.0 |
|
2.3 |
|
7.1 |
|
9.6 |
|
6.3 |
|
9.9 |
|
5.9 |
|
Total operating revenues |
|
1.9 |
|
5.0 |
|
(.8 |
) |
7.6 |
|
6.4 |
|
6.2 |
|
6.6 |
|
6.4 |
|
Pretax operating earnings* |
|
3.8 |
|
13.2 |
|
7.3 |
|
15.0 |
|
8.4 |
|
14.5 |
|
15.3 |
|
13.7 |
|
* See Page 26 for our definition of segment operating earnings.
The percentage increases in premium income reflect the growth of premiums in force. Annualized premiums in force in yen increased 5.9% to 1.07 trillion yen as of September 30, 2006, compared with 1.01 trillion yen a year ago, and reflect the high persistency of Aflac Japans business and the sales of new policies. Annualized premiums in force, translated into dollars at respective period-end exchange rates, were $9.1 billion at September 30, 2006, compared with $8.9 billion a year ago.
Aflac Japan maintains a portfolio of dollar-denominated and reverse-dual currency securities (yen-denominated debt securities with dollar coupon payments). Dollar-denominated investment income from these assets accounted for approximately 37% of Aflac Japans investment income in the first nine months of 2006, compared with 31% a year ago. In periods when the yen strengthens in relation to the dollar, translating Aflac Japans dollar-denominated investment income into yen lowers
27
growth rates for net investment income, total operating revenues, and pretax operating earnings in yen terms. In periods when the yen weakens, translating dollar-denominated investment income into yen magnifies growth rates for net investment income, total operating revenues, and pretax operating earnings in yen terms. On a constant currency basis, dollar-denominated investment income accounted for approximately 35% of Aflac Japans investment income during the first nine months of 2006. The following table illustrates the effect of translating Aflac Japans dollar-denominated investment income and related items into yen by comparing certain segment results with those that would have been reported had yen/dollar exchange rates remained unchanged from the comparable period in the prior year.
Aflac Japan Percentage Changes Over Previous Period
Yen Operating Results
For the Periods Ended September 30,
|
Including Foreign Currency Changes |
|
Excluding Foreign Currency Changes** |
||||||||||||||
|
|
Three Months |
|
Nine Months |
|
Three Months |
|
Nine Months |
|
||||||||
|
|
2006 |
|
2005 |
|
2006 |
|
2005 |
|
2006 |
|
2005 |
|
2006 |
|
2005 |
|
Net investment |
|
9.6 |
% |
6.3 |
% |
9.9 |
% |
5.9 |
% |
7.8 |
% |
5.9 |
% |
7.1 |
% |
6.2 |
% |
Total operating |
|
6.4 |
|
6.2 |
|
6.6 |
|
6.4 |
|
6.2 |
|
6.2 |
|
6.2 |
|
6.5 |
|
Pretax operating earnings* |
|
8.4 |
|
14.5 |
|
15.3 |
|
13.7 |
|
6.7 |
|
14.1 |
|
12.6 |
|
14.0 |
|
* See Page 26 for our definition of segment operating earnings.
** Amounts excluding foreign currency changes on dollar-denominated items were determined using the same yen/dollar exchange rate for the current period as the comparable period in the prior year.
The following table presents a summary of operating ratios for Aflac Japan.
|
Three Months Ended |
|
Nine Months Ended |
|
|||||||||||||
Ratios to total revenues, in dollars: |
|
2006 |
|
2005 |
|
2006 |
|
2005 |
|
||||||||
Benefits and claims |
|
|
66.1 |
% |
|
|
66.6 |
% |
|
|
65.3 |
% |
|
|
66.4 |
% |
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortization of deferred policy acquisition costs |
|
|
2.6 |
|
|
|
2.7 |
|
|
|
2.7 |
|
|
|
2.7 |
|
|
Insurance commissions |
|
|
8.0 |
|
|
|
8.3 |
|
|
|
8.2 |
|
|
|
8.6 |
|
|
Insurance and other expenses |
|
|
7.9 |
|
|
|
7.3 |
|
|
|
7.7 |
|
|
|
7.4 |
|
|
Total operating expenses |
|
|
18.5 |
|
|
|
18.3 |
|
|
|
18.6 |
|
|
|